Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs EXE✓SelectedUSD · EXEMRNA vs EXE performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs EXE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
EXE return
+67.3%
Excess return
-98.3%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioEXEExcessAlpha
1D-2.2%-1.4%-0.8%-2.0%
7D-12.7%-8.2%-4.5%-11.6%
30D-20.7%-11.9%-8.8%-19.3%
3M+46.3%-14.9%+61.1%+49.3%
6M+305.2%-16.8%+322.0%+314.8%
YTD+561.2%-24.6%+585.8%+585.5%
1Y+772.1%-27.3%+799.4%+809.6%
3Y+147.0%+8.1%+138.9%+136.7%
All-31.0%+67.3%-98.3%-34.6%

Cumulative growth

Daily Returns

Daily percentage return beside EXE.

Daily Out/Under-Performance

Portfolio return minus EXE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × EXE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded EXE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling